The estimated Net Worth of Marco Dolci is at least $1.07 Million dollars as of 30 March 2023. Mr. Dolci owns over 3,563 units of LivaNova PLC stock worth over $381,308 and over the last 5 years he sold LIVN stock worth over $686,329. In addition, he makes $0 as Head of Global Operations and R&D at LivaNova PLC.
Marco has made over 14 trades of the LivaNova PLC stock since 2020, according to the Form 4 filled with the SEC. Most recently he exercised 3,563 units of LIVN stock worth $169,064 on 30 March 2023.
The largest trade he's ever made was selling 8,278 units of LivaNova PLC stock on 18 May 2021 worth over $686,329. On average, Marco trades about 2,428 units every 80 days since 2020. As of 30 March 2023 he still owns at least 8,036 units of LivaNova PLC stock.
You can see the complete history of Mr. Dolci stock trades at the bottom of the page.
Marco Dolci serves as Head of Global Operations and R&D of the Company. Marco Dolci joined LivaNova in March 2017 as President, Europe and subsequently became President, Europe and Head of Global Manufacturing Operations (December 2018 to January 2020) and has been in his current role as Head of Global Operations and R&D since January 2020. Prior to joining the Company, Mr. Dolci was with Danaher Corporation as its Vice President of Danaher Business System?–?Dental Consumable Platform (April 2016 to March 2017); President of Global Digital Dentistry (November 2014 to April 2016); President?–?Dental Consumable Platform?–?EMEA, Asia and Pacific Region (December 2012 to December 2014); and President, Kerr EMEA (October 2010 to December 2012). Prior to his tenure at Danaher, Mr. Dolci served as President and CEO, EMEA for Hitachi Medical System Europe Holding AG. Earlier in his career, he worked in various positions at Eastman Kodak S.A.?–?Health Care Division, GE Healthcare and Philips Medical Systems. Mr. Dolci holds a master’s degree in nuclear physics from University of Milan and an Executive M.B.A. from Polytechnic University of Milan.
Marco Dolci is 58, he's been the Head of Global Operations and R&D of LivaNova PLC since 2020. There are 9 older and 11 younger executives at LivaNova PLC. The oldest executive at LivaNova PLC is Arthur Rosenthal, 73, who is the Independent Director.
Marco's mailing address filed with the SEC is 20 EASTBOURNE TERRACE, , LONDON, X0, W26LG.
Over the last 9 years, insiders at LivaNova PLC have traded over $79,802,010 worth of LivaNova PLC stock and bought 4,000 units worth $268,530 . The most active insiders traders include William A Kozy, Two S.C.A.Tower 6 S. A R.L.... und Peter M Wilver. On average, LivaNova PLC executives and independent directors trade stock every 10 days with the average trade being worth of $315,922. The most recent stock trade was executed by Peter M Wilver on 15 June 2024, trading 2,680 units of LIVN stock currently worth $127,166.
livanova plc is a global medical technology company built on nearly five decades of experience and a relentless commitment to improve the lives of patients around the world. our advanced technologies and breakthrough treatments provide meaningful solutions for the benefit of patients, healthcare professionals and healthcare systems.at livanova, we understand the importance of bringing both clinical and economic value to our customers. we are a strong, market-leading medical technology and services company, offering a diverse product portfolio and global reach. livanova is listed on the nasdaq stock exchange under the ticker symbol “livn.” livanova has approximately 3,000 employees worldwide. we are headquartered in london (uk) and maintain a presence in more than 100 countries. livanova is a worldwide leader in advanced circulatory support, cardiopulmonary and neuromodulation, dedicated to creating meaningful products and therapies that transform lives each and every day.
LivaNova PLC executives and other stock owners filed with the SEC include: